Literature DB >> 19171982

Quality of life in psoriasis: a study from south India.

S V Rakhesh1, Mariette D'Souza, Ajith Sahai.   

Abstract

BACKGROUND: Psoriasis can have a profound impact on a patient's quality of life. Very few Indian studies have examined this aspect of Indian patients of psoriasis. AIMS: This study was conducted to assess the clinical severity, as well as physical and psychosocial disability, and stress incurred and to analyze their interrelationship in psoriasis patients aged more than 18 years.
METHODS: This hospital-based cross-sectional study was conducted in the Department of Dermatology, JIPMER, Pondicherry, India. Clinical severity, physical and psychosocial morbidity, and the stress incurred were measured using psoriasis area severity index (PASI), psoriasis disability index (PDI), and psoriasis life stress inventory (PLSI) respectively, the latter two of which were suitably modified and translated into the local language, viz., Tamil. Appropriate tests were conducted using SPSS for Windows (Release 7.5.1) statistical software.
RESULTS: Fifty patients (34 males, 16 females) were included in the study. The clinical PASI scores correlated significantly with the overall physical disability (PDI), individual aspects of the PDI (except the treatment-related activities), and the measurement of stress incurred (PLSI). A PASI score of more than 18 delineated a subgroup of patients with higher overall physical disability and higher stress rating. Among the physical and psychosocial factors investigated, daily activities, employment, and treatment were reported to be affected the most. Psoriasis sufferers are also most likely to feel self-conscious, be disturbed / inconvenienced by the shedding of the skin, live in a constant fear of relapse, and avoid social interactions.
CONCLUSIONS: The present study provides compelling evidence that psoriasis affects the quality of life, and it highlights the importance of adopting a multidimensional assessment of psoriasis.

Entities:  

Mesh:

Year:  2008        PMID: 19171982     DOI: 10.4103/0378-6323.45101

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  12 in total

1.  Psoriasis: correlation between severity index (PASI) and quality of life index (DLQI) in patients assessed before and after systemic treatment.

Authors:  Maria Flávia Pereira da Silva; Maria Rita Parise Fortes; Luciane Donida Bartoli Miot; Silvio Alencar Marques
Journal:  An Bras Dermatol       Date:  2013 Sep-Oct       Impact factor: 1.896

2.  A study of psoriasis and quality of life in a tertiary care teaching hospital of kottayam, kerala.

Authors:  V D Manjula; S Sreekiran; P Surendran Saril; M P Sreekanth
Journal:  Indian J Dermatol       Date:  2011-07       Impact factor: 1.494

3.  Pasi and pqol-12 score in psoriasis: is there any correlation?

Authors:  Vikas Shankar; Sanjay Ghosh; Kisalay Ghosh; Uday Chaudhuri
Journal:  Indian J Dermatol       Date:  2011-05       Impact factor: 1.494

4.  General measures and quality of life issues in psoriasis.

Authors:  Rashmi Sarkar; Shikha Chugh; Shivani Bansal
Journal:  Indian Dermatol Online J       Date:  2016 Nov-Dec

5.  Clinical Outcome of a Novel Anti-CD6 Biologic Itolizumab in Patients of Psoriasis with Comorbid Conditions.

Authors:  Vinay Singh
Journal:  Dermatol Res Pract       Date:  2016-11-02

6.  Quality of life outcomes in adults with moderate-to-severe plaque psoriasis treated with dimethylfumarate (DMF): a post hoc analysis of the BRIDGE study.

Authors:  P C M van de Kerkhof; R Loewe; U Mrowietz; M Falques; I Pau-Charles; J C Szepietowski
Journal:  J Eur Acad Dermatol Venereol       Date:  2019-10-17       Impact factor: 6.166

7.  Correlation of Venous Clinical Severity Score and Venous Disability Score with Dermatology Life Quality Index in Chronic Venous Insufficiency.

Authors:  Subhadeep Mallick; Tanusree Sarkar; Tirthankar Gayen; Biswanath Naskar; Adrija Datta; Somenath Sarkar
Journal:  Indian J Dermatol       Date:  2020 Nov-Dec       Impact factor: 1.494

8.  Improvement of health-related quality of life and adherence to treatment with calcipotriol-betamethasone dipropionate gel in patients with psoriasis vulgaris.

Authors:  George Kontochristopoulos; Anargyros Kouris; Athanasios Chantzaras; Athanasios Petridis; John Yfantopoulos
Journal:  An Bras Dermatol       Date:  2016-04       Impact factor: 1.896

9.  Effect of an Educational and Psychological Intervention on Knowledge and Quality of Life among Patients with Psoriasis.

Authors:  Padmavathi Nagarajan; Devinder Mohan Thappa
Journal:  Indian Dermatol Online J       Date:  2018 Jan-Feb

10.  Narrow-band UVB Phototherapy does not Consistently Improve Quality of Life in Psoriasis Patients: A Prospective Observational Study from Eastern India.

Authors:  Shweta Arora; Bikash R Kar
Journal:  Indian Dermatol Online J       Date:  2018 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.